{
    "2019-02-13": [
        [
            {
                "time": "2019-02-13",
                "original_text": "明日最具投资机会六大牛股一览（2019年2月13日）",
                "features": {
                    "keywords": [
                        "投资机会",
                        "牛股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-13",
                "original_text": "国盛证券：智飞生物买入评级",
                "features": {
                    "keywords": [
                        "国盛证券",
                        "智飞生物",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-13",
                "original_text": "券商首次关注3股并给予买入评级（2月13日）",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-13",
                "original_text": "30股获券商买入评级 天能重工目标涨幅达68.99%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "天能重工",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-13",
                "original_text": "【朝闻国盛0213】深度报告：新北洋-智能大时代蓝海加速成长；智飞生物-疫苗龙头业绩持续高速增长",
                "features": {
                    "keywords": [
                        "新北洋",
                        "智能大时代",
                        "智飞生物",
                        "疫苗龙头",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "信息技术",
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-13",
                "original_text": "精准生物白血病新药获准临床 智飞生物联手实际控制人间接参股",
                "features": {
                    "keywords": [
                        "精准生物",
                        "白血病新药",
                        "智飞生物",
                        "实际控制人",
                        "间接参股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "医药生物行业2019年2月月报:政策明朗,兼顾安全与成长性",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策明朗",
                        "安全",
                        "成长性"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}